Home>>Signaling Pathways>> Microbiology & Virology>> SARS-CoV>>Riamilovir

Riamilovir (Synonyms: Triazavirin)

Catalog No.GC25863

Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV.

Products are for research use only. Not for human use. We do not sell to patients.

Riamilovir Chemical Structure

Cas No.: 123606-06-4

Size Price Stock Qty
25mg
$325.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV.

[1] Shahab S, et al. Curr Mol Med. 2021;21(8):645-654.

Reviews

Review for Riamilovir

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Riamilovir

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.